Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Exelixis, Inc. a biopharmaceutical company based in South San Francisco, will reduce its workforce by approximately 70%, or approximately 160 employees, resulting in approximately 70 remaining employees. The move comes after not meeting a...

Actavis plc reports that the US Food and Drug Administrationhas accepted for filing Actavis' new drug application (NDA) for eluxadoline, an oral investigational drug for the treatment of diarrhea and abdominal pain in men and women with diarrhea...

Merck KGaA´s biopharmaceuticals division has broken ground for its new pharmaceutical manufacturing facility in Nantong, China. The new facility, which will be the company's second-largest pharmaceutical manufacturing facility worldwide, will...

Merck KGaA has begun construction of a modular Innovation Center at its site in Darmstadt, Germany, as part of an overall expansion of the Darmstadt site, including the company's headquarters. The expansion is part of the company's strategic "Fit...

Allergan, Inc. has asked the United States District Court for the Central District of California to set an expedited schedule for discovery and a motion for a preliminary injunction against Valeant Pharmaceuticals, Pershing Square Capital...

Amgen has submitted a biologics license application (BLA) to the US Food and Drug Administration (FDA) for evolocumab to treat high cholesterol. Evolocumab is an investigational fully human monoclonal antibody that inhibits proprotein...